Yong-rim Kwon

Seoul St. Mary's Hospital, Seoul 06591
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Analysis of chromatin accessibility associated with azacitidine response in higher-risk myelodysplastic neoplasms.

Analysis of chromatin accessibility associated with azacitidine response in higher-risk myelodysplastic neoplasms.

Journal: iScience

Published: April 15, 2025

Potential role of miR-29b from mesenchymal stromal cell-derived extracellular vesicles in leukemic cell progression.

Potential role of miR-29b from mesenchymal stromal cell-derived extracellular vesicles in leukemic cell progression.

Journal: PloS one

Published: January 24, 2025

Impaired binding affinity of YTHDC1 with METTL3/METTL14 results in R-loop accumulation in myelodysplastic neoplasms with DDX41 mutation.

Impaired binding affinity of YTHDC1 with METTL3/METTL14 results in R-loop accumulation in myelodysplastic neoplasms with DDX41 mutation.

Journal: Leukemia

Published: September 13, 2023

Clinical implications of copy number alteration detection using panel-based next-generation sequencing data in myelodysplastic syndrome.

Clinical implications of copy number alteration detection using panel-based next-generation sequencing data in myelodysplastic syndrome.

Journal: Leukemia research

Published: November 13, 2020

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells.

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells.

Journal: Experimental hematology & oncology

Published: March 26, 2020

Gene expression signatures associated with sensitivity to azacitidine in myelodysplastic syndromes.

Gene expression signatures associated with sensitivity to azacitidine in myelodysplastic syndromes.

Journal: Scientific reports

Published: January 29, 2020

Enhanced polo-like kinase 1 expression in myelodysplastic syndromes.

Enhanced polo-like kinase 1 expression in myelodysplastic syndromes.

Journal: Blood research

Published: November 09, 2018

TP53 mutation in allogeneic hematopoietic cell transplantation for de novo myelodysplastic syndrome.

TP53 mutation in allogeneic hematopoietic cell transplantation for de novo myelodysplastic syndrome.

Journal: Leukemia research

Published: July 30, 2018

Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients.

Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients.

Journal: Stem cell research & therapy

Published: February 01, 2018

Forced expression of CD200 improves the differentiation capability and immunoregulatory functions of mesenchymal stromal cells.

Forced expression of CD200 improves the differentiation capability and immunoregulatory functions of mesenchymal stromal cells.

Journal: Biotechnology letters

Published: November 22, 2017

Enhanced differentiation of mesenchymal stromal cells by three-dimensional culture and azacitidine.

Enhanced differentiation of mesenchymal stromal cells by three-dimensional culture and azacitidine.

Journal: Blood research

Published: November 10, 2016

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome.

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome.

Journal: Oncotarget

Published: January 12, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026